Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression Patients

NCT06439797 is registered in ClinicalTrials.gov with The Chaim Sheba Medical Center as lead sponsor.

NCT NCT06439797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06439797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression Patients
Lead sponsor
The Chaim Sheba Medical Center
Phase
Observational
Overall status
Completed
Start date
November 29, 2018
Completion date
July 9, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healty controls, major depressive disorder